Late-Life Depression Is Associated With Reduced Cortical Amyloid Burden: Findings From the Alzheimer’s Disease Neuroimaging Initiative Depression Project
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background: To evaluate the role of cortical amyloid deposition as a factor contributing to memory dysfunction and increased risk of dementia associated with late life depression (LLD). Methods: 119 older adult participants with current diagnosis of Major Depression (LLD) from the ADNI Depression study and 119 non-depressed (ND) cognitively unimpaired participants matched on age, gender, and APOE genotype obtained from the ADNI database. Results: Thirty-three percent of LLD participants met ADNI criteria for MCI. Compared to ND individuals, the LLD group exhibited less global amyloid (Aβ) accumulation (p = 0.05). The proportion of amyloid positivity in the LLD group was 19.3% compared to 31.1% for the ND participants (p =0.02). Among LLD participants, global Aβ was not associated with lifetime number of depressive episodes, lifetime length of depression, length of lifetime SSRI use, or lifetime length of untreated depression (p > 0.21 for all). Global Aβ was associated with worse memory performance (p = 0.05). Similar results were found in secondary analyses restricting comparisons to the cognitively unimpaired LLD participants and also when comparing the LLD group to a ND group which included MCI participants. Conclusions: Contrary to expectation, the LLD group showed less Aβ deposition than ND and Aβ deposition was not associated with depression history characteristics. Aβ was associated with memory but this relationship did not differ between LLD and ND. Our results suggest that memory deficits and accelerated cognitive decline reported in previous studies of late life depression is not due to greater cortical Aβ accumulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression and risk of developing dementia
Byers, A. L., & Yaffe, K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.60 · Cited by 1,265 · cited 1×
“…nding of reduced amyloid in our depression sample was not expected given prior literature stating that LLD is a risk factor for accelerated cognitive decline and the development of both MCI and dementia (1,9,48), the comorbidity of LLD and AD (49), and cerebrospinal fl uid studies of A b (19 – 21).”
The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression
Butters, M. A., Whyte, E. M., Nebes, R. D., Begley, A. E., Dew, M. A., Mulsant, B. H., Zmuda, M. D., Bhalla, R., Meltzer, C. C., Pollock, B. G., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.587 · Cited by 622 · cited 1×
“Exclusion of participants with MCI from the ND group in the primary analysis was done to provide the most conservative point of comparison for measures of A b PET SUVR be-tween groups because major depression has consistently been associated with memory impairments independent of AD (36,37).”
Self-citationDepressive symptoms, cognitive decline, and risk of AD in older persons
Wilson, R. S., Barnes, L. L., Mendes de Leon, C. F., Aggarwal, N. T., Schneider, J. S., Bach, J., Pilat, J., Beckett, L. A., Arnold, S. E., Evans, D. A., et al. (2002) · Neurology · doi:10.1212/wnl.59.3.364 · Cited by 528
Neurocognitive impairment in drug-free patients with major depressive disorder
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519
Depressive symptoms and risk of dementia: The Framingham Heart Study
Saczynski, J. S., Beiser, A., Seshadri, S., Auerbach, S., Wolf, P. A., & Au, R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e62138 · Cited by 488 · cited 1×
“…Subsyndromal symptoms of depression and major depression in older adults are among the most consistently re-ported risk factors associated with more rapid rates of future cognitive decline (1 – 8), more rapid conversion to dementia (9,10), and higher rates of incident dementia (11).”
Neurocognitive deficits and disability in major depressive disorder
Jaeger, J., Berns, S., Uzelac, S., & Davis-Conway, S. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.11.011 · Cited by 484
Late-life depression, mild cognitive impairment, and dementia
Richard, E., Reitz, C., Honig, L. H., Schupf, N., Tang, M. X., Manly, J. J., Mayeux, R., Devanand, D., & Luchsinger, J. A. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.603 · Cited by 389 · cited 2×
“Speci fi cally, subsyndromal symptoms of depression have been linked to a 2.4-fold increased risk for dementia (12), whereas major depression has been linked to a nearly 4.3-fold increased risk for dementia (13).”
InfluentialDonovan, N. J., Locascio, J. J., Marshall, G. A., Gatchel, J., Hanseeuw, B. J., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Study, F. T. H. A. B. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17040442 · Cited by 272
An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice
Sheline, Y. I., West, T., Yarasheski, K., Swarm, R., Jasielec, M. S., Fisher, J. R., Ficker, W. D., Yan, P., Xiong, C., Frederiksen, C., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008169 · Cited by 223
Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?
Sun, X., Steffens, D. C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Mwamburi, D. M., & Qiu, W. Q. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.542 · Cited by 174 · cited 2×
“…A b deposition was found in autopsy studies showing an association between amyloid plaques in dementia patients with a history of major depression (18,19) as well as in studies of plasma A b 40 and cerebrospinal fl uid A b 42 levels that indicate altered metabolism of A b in LLD (14,20,21).”
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients
Initiative, F. T. A. D. N., Brendel, M., Pogarell, O., Xiong, G., Delker, A., Bartenstein, P., & Rominger, A. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2975-4 · Cited by 94
Lack of association between prior depressive episodes and cerebral [11C]PiB binding
Madsen, K., Hasselbalch, B. J., Frederiksen, K. S., Haahr, M. E., Gade, A., Law, I., Price, J. C., Knudsen, G. M., Kessing, L. V., & Hasselbalch, S. G. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.021 · Cited by 66
Depressive Symptoms and Cognitive Decline in Nondemented Elderly Women: A Prospective Study
Yaffe, K., Blackwell, T., Gore, R., Sands, L., Reus, V., & Browner, W. S. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.425 · Cited by 8 · cited 2×
“…Subsyndromal symptoms of depression and major depression in older adults are among the most consistently re-ported risk factors associated with more rapid rates of future cognitive decline (1 – 8), more rapid conversion to dementia (9,10), and higher rates of incident dementia (11).”
Cited by
Depression in Alzheimer’s Disease: Epidemiology, Mechanisms, and Treatment
Huang, Y.-Y., Gan, Y.-H., Yang, L., Cheng, W., & Yu, J.-T. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.10.008 · Cited by 164
Veitch, D. P., Weiner, M. W., Miller, M., Aisen, P. S., Ashford, M. A., Beckett, L. A., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13449 · Cited by 113
Self-citationSouchet, B., Michaïl, A., Heuillet, M., Dupuy-Gayral, A., Haudebourg, E., Pech, C., Berthemy, A., Autelitano, F., Billoir, B., Domoto-Reilly, K., et al. (2024) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2024.34 · Cited by 15
“…Lewy body dementia (19), cortical basal syndrome (20), post-stroke neurodegeneration (21), schizophrenia (22), alcohol-related cognitive disorders (23), and late-life depression (24), amyloid status (positive or negative) does not significantly influence symptom severity or cognitive decline rate.”
BackgroundUrine 3-Nitrotyrosine and serum HDL as potential biomarkers of depression
Nobis, A., Zalewski, D., Samaryn, E., Maciejczyk, M., Zalewska, A., & Waszkiewicz, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12010377 · Cited by 12
“In the majority of PET studies, higher levels of cortical β-amyloid deposition were found in elderly depressive patients [17–19], while contradictory results have also been reported [20,21].”
Result
Metadata
- Authors
- Mackin, R. S., Insel, P. S., Landau, S., Bickford, D., Morin, R., Rhodes, E., Tosun, D., Rosen, H. J., Butters, M., Aisen, P., Raman, R., Saykin, A., Toga, A., Jack, C., Koeppe, R., Weiner, M. W., & Nelson, C.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 89
- Issue
- 8
- Pages
- 757-765
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W3038666820
- Cited by
- 75
- References
- 13
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.